243 related articles for article (PubMed ID: 21858774)
1. Tumor blood vessel visualization.
Missbach-Guentner J; Hunia J; Alves F
Int J Dev Biol; 2011; 55(4-5):535-46. PubMed ID: 21858774
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive imaging for studying anti-angiogenic therapy effects.
Ehling J; Lammers T; Kiessling F
Thromb Haemost; 2013 Mar; 109(3):375-90. PubMed ID: 23407722
[TBL] [Abstract][Full Text] [Related]
3. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis.
Drevs J; Schneider V
J Intern Med; 2006 Dec; 260(6):517-29. PubMed ID: 17116002
[TBL] [Abstract][Full Text] [Related]
4. Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis.
García-Figueiras R; Padhani AR; Beer AJ; Baleato-González S; Vilanova JC; Luna A; Oleaga L; Gómez-Caamaño A; Koh DM
Curr Probl Diagn Radiol; 2015; 44(5):407-24. PubMed ID: 25890454
[TBL] [Abstract][Full Text] [Related]
5. Imaging the effects of anti-angiogenic treatments.
Vāvere AL; Lewis JS
Q J Nucl Med; 2003 Sep; 47(3):163-70. PubMed ID: 12897708
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles for molecular imaging--an overview.
Minchin RF; Martin DJ
Endocrinology; 2010 Feb; 151(2):474-81. PubMed ID: 20016027
[TBL] [Abstract][Full Text] [Related]
7. The role of imaging in the clinical development of antiangiogenic agents.
Morgan B; Horsfield MA; Steward WP
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1183-206, x. PubMed ID: 15474341
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of tumor angiogenesis.
Costouros NG; Diehn FE; Libutti SK
J Cell Biochem Suppl; 2002; 39():72-8. PubMed ID: 12552605
[TBL] [Abstract][Full Text] [Related]
9. Imaging angiogenesis: applications and potential for drug development.
Miller JC; Pien HH; Sahani D; Sorensen AG; Thrall JH
J Natl Cancer Inst; 2005 Feb; 97(3):172-87. PubMed ID: 15687360
[TBL] [Abstract][Full Text] [Related]
10. Options for visualizing metastatic disease in the living body.
Helms MW; Brandt BH; Contag CH
Contrib Microbiol; 2006; 13():209-231. PubMed ID: 16627968
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging in vivo: an introduction.
Dzik-Jurasz AS
Br J Radiol; 2003; 76 Spec No 2():S98-109. PubMed ID: 15572339
[No Abstract] [Full Text] [Related]
12. Tumor angiogenesis targeting using imaging agents.
Weber WA; Haubner R; Vabuliene E; Kuhnast B; Wester HJ; Schwaiger M
Q J Nucl Med; 2001 Jun; 45(2):179-82. PubMed ID: 11476168
[TBL] [Abstract][Full Text] [Related]
13. Imaging in drug development.
Herbst RS
Clin Adv Hematol Oncol; 2004 May; 2(5):268-9. PubMed ID: 16163191
[No Abstract] [Full Text] [Related]
14. Tumor Blood Vessel Visualization.
Gillmann C; Bäuerle T
Methods Mol Biol; 2016; 1464():163-173. PubMed ID: 27858365
[TBL] [Abstract][Full Text] [Related]
15. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
Höink AJ; Heindel W; Buerke B
Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
[TBL] [Abstract][Full Text] [Related]
16. Imaging vascular physiology to monitor cancer treatment.
Laking GR; West C; Buckley DL; Matthews J; Price PM
Crit Rev Oncol Hematol; 2006 May; 58(2):95-113. PubMed ID: 16387510
[TBL] [Abstract][Full Text] [Related]
17. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging.
Sun Y; Zhu X; Peng J; Li F
ACS Nano; 2013 Dec; 7(12):11290-300. PubMed ID: 24205939
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive assessment of tumor neovasculature: techniques and clinical applications.
Perini R; Choe R; Yodh AG; Sehgal C; Divgi CR; Rosen MA
Cancer Metastasis Rev; 2008 Dec; 27(4):615-30. PubMed ID: 18506398
[TBL] [Abstract][Full Text] [Related]
19. Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives.
Niccoli Asabella A; Di Palo A; Altini C; Ferrari C; Rubini G
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28846661
[TBL] [Abstract][Full Text] [Related]
20. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
